These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15217580)

  • 1. [Comment on the article by M. Henke: "Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double blind, placebo controlled trial" or how a cytokine remains a cytokine].
    Lartigau E; Denis F
    Cancer Radiother; 2004 Jun; 8(3):131-3. PubMed ID: 15217580
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Gemici C
    Lancet; 2004 Mar; 363(9413):992-3; author reply 993. PubMed ID: 15043975
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Vaupel P; Mayer A
    Lancet; 2004 Mar; 363(9413):992; author reply 993. PubMed ID: 15043976
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Janecka IP
    Lancet; 2004 Mar; 363(9413):993-4. PubMed ID: 15043978
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Blumberg N; Heal JM
    Lancet; 2004 Jan; 363(9402):80-1; author reply 81-2. PubMed ID: 14724011
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Haddad R; Posner M
    Lancet; 2004 Jan; 363(9402):79-80; author reply 81-2. PubMed ID: 14724009
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Powles T; Shamash J; Liu W
    Lancet; 2004 Jan; 363(9402):82. PubMed ID: 14724015
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
    Henke M; Laszig R; Rübe C; Schäfer U; Haase KD; Schilcher B; Mose S; Beer KT; Burger U; Dougherty C; Frommhold H
    Lancet; 2003 Oct; 362(9392):1255-60. PubMed ID: 14575968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversial effect of epoetin in cancer: grounds for a translational research exercise?
    Apolone G
    Eur J Cancer; 2004 Jun; 40(9):1289-91. PubMed ID: 15177486
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Freidlin B; Korn EL
    Lancet; 2004 Jan; 363(9402):81; author reply 81-2. PubMed ID: 14724012
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Kaanders JH; van der Kogel AJ
    Lancet; 2004 Jan; 363(9402):78-9; author reply 81-2. PubMed ID: 14724007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erythropoietin and anemia: when quality of life and survival clash].
    Fayette J
    Bull Cancer; 2003 Dec; 90(12):1033. PubMed ID: 14715420
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Leyland-Jones B; Mahmud S
    Lancet; 2004 Jan; 363(9402):80; author reply 81-2. PubMed ID: 14724010
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
    Rades D
    Oral Oncol; 2009 Feb; 45(2):91-3. PubMed ID: 18490191
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
    Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
    J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
    Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
    Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
    Henke M; Mattern D; Pepe M; Bézay C; Weissenberger C; Werner M; Pajonk F
    J Clin Oncol; 2006 Oct; 24(29):4708-13. PubMed ID: 17028293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia correction in malignancy management: threat or opportunity?
    De Los Santos JF; Thomas GM
    Gynecol Oncol; 2007 May; 105(2):517-29. PubMed ID: 17367848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.